Jane Street’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-59,305
| Closed | -$733K | – | 11243 |
|
|
2025
Q3 | $733K | Buy |
59,305
+4,962
| +9% | +$58.2K | ﹤0.01% | 6989 |
|
|
2025
Q2 | $626K | Sell |
54,343
-32,320
| -37% | -$383K | ﹤0.01% | 6517 |
|
|
2025
Q1 | $1.3M | Sell |
86,663
-24,690
| -22% | -$413K | ﹤0.01% | 5083 |
|
|
2024
Q4 | $1.93M | Buy |
111,353
+39,364
| +55% | +$760K | ﹤0.01% | 4171 |
|
|
2024
Q3 | $1.33M | Buy |
71,989
+25,189
| +54% | +$506K | ﹤0.01% | 5294 |
|
|
2024
Q2 | $950K | Buy |
+46,800
| New | +$828K | ﹤0.01% | 5870 |
|
|
2024
Q1 | – | Sell |
-47,397
| Closed | -$745K | – | 9264 |
|
|
2023
Q4 | $837K | Buy |
+47,397
| New | +$955K | ﹤0.01% | 5883 |
|
|
2023
Q3 | – | Sell |
-29,252
| Closed | -$680K | – | 8701 |
|
|
2023
Q2 | $680K | Sell |
29,252
-52,384
| -64% | -$1.18M | ﹤0.01% | 5839 |
|
|
2023
Q1 | $1.8M | Buy |
81,636
+43,266
| +113% | +$1.01M | ﹤0.01% | 4005 |
|
|
2022
Q4 | $778K | Buy |
38,370
+10,615
| +38% | +$206K | ﹤0.01% | 5392 |
|
|
2022
Q3 | $375K | Buy |
27,755
+11,225
| +68% | +$189K | ﹤0.01% | 7204 |
|
|
2022
Q2 | $328K | Sell |
16,530
-27,657
| -63% | -$735K | ﹤0.01% | 7466 |
|
|
2022
Q1 | $1.4M | Buy |
+44,187
| New | +$1.24M | ﹤0.01% | 5430 |
|
|
2021
Q4 | – | Sell |
-31,360
| Closed | -$818K | – | 10127 |
|
|
2021
Q3 | $871K | Buy |
31,360
+5,585
| +22% | +$170K | ﹤0.01% | 6191 |
|
|
2021
Q2 | $1M | Sell |
25,775
-34,804
| -57% | -$1.25M | ﹤0.01% | 5839 |
|
|
2021
Q1 | $1.74M | Buy |
60,579
+40,642
| +204% | +$1.39M | ﹤0.01% | 4292 |
|
|
2020
Q4 | $529K | Buy |
+19,937
| New | +$407K | ﹤0.01% | 5644 |
|
|
2020
Q3 | – | Sell |
-325,629
| Closed | -$6.83M | – | 7191 |
|
|
2020
Q2 | $6.62M | Buy |
325,629
+311,865
| +2,266% | +$5.59M | 0.01% | 1539 |
|
|
2020
Q1 | $142K | Sell |
13,764
-14,151
| -51% | -$396K | ﹤0.01% | 4795 |
|
|
2019
Q4 | $1.05M | Buy |
+27,915
| New | +$1.25M | ﹤0.01% | 2715 |
|
|
2019
Q3 | – | Sell |
-23,311
| Closed | -$1.22M | – | 5132 |
|
|
2019
Q2 | $1.22M | Buy |
23,311
+18,646
| +400% | +$1.09M | ﹤0.01% | 2443 |
|
|
2019
Q1 | $322K | Sell |
4,665
-23,120
| -83% | -$1.55M | ﹤0.01% | 4174 |
|
|
2018
Q4 | $1.66M | Buy |
27,785
+22,614
| +437% | +$1.95M | ﹤0.01% | 1949 |
|
|
2018
Q3 | $599K | Buy |
+5,171
| New | +$583K | ﹤0.01% | 3398 |
|
|
2018
Q2 | – | Sell |
-2,109
| Closed | -$257K | – | 5013 |
|
|
2018
Q1 | $228K | Sell |
2,109
-2,874
| -58% | -$318K | ﹤0.01% | 4323 |
|
|
2017
Q4 | $546K | Buy |
+4,983
| New | +$497K | ﹤0.01% | 3066 |
|
|
2017
Q3 | – | Sell |
-2,933
| Closed | -$284K | – | 4490 |
|
|
2017
Q2 | $297K | Sell |
2,933
-6,028
| -67% | -$650K | ﹤0.01% | 3606 |
|
|
2017
Q1 | $1.03M | Buy |
+8,961
| New | +$1.04M | ﹤0.01% | 2041 |
|
|
2016
Q4 | – | Sell |
-1,950
| Closed | -$216K | – | 4055 |
|
|
2016
Q3 | $219K | Sell |
1,950
-437
| -18% | -$50.3K | ﹤0.01% | 3613 |
|
|
2016
Q2 | $296K | Buy |
+2,387
| New | +$288K | ﹤0.01% | 3331 |
|
|
2016
Q1 | – | Sell |
-4,949
| Closed | -$514K | – | 4095 |
|
|
2015
Q4 | $538K | Buy |
+4,949
| New | +$567K | ﹤0.01% | 2399 |
|
Other funds holding CLB
AI
DGI
Jane Street's CLB Position: Q4 2025 in Review
Jane Street sold out of Core Laboratories (CLB) in Q4 2025, closing a stake of 59,305 shares — an estimated $733K sold.
Jane Street first reported a position in CLB in Q4 2015 and held it in 31 quarters. The position peaked at $6.62M in Q2 2020. 187 funds tracked by Wall St. Rank hold CLB as of Q4 2025.
- Jane Street reported no remaining Core Laboratories position as of Q4 2025 after selling out during the quarter.
- Jane Street sold 59,305 Core Laboratories shares in Q4 2025, an estimated $733K.
- Jane Street first reported a position in Core Laboratories in Q4 2015 and held it in 31 quarters.
- Jane Street's Core Laboratories position peaked at $6.62M in Q2 2020.
- 187 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2025.
Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.